Category: Merger/Acquisition Region: Asia · Israel Company: Purple Biotech Ltd

Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri Specific Antibodies for the Treatment of Cancer

By, Admin 1 min read
Share
Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri Specific Antibodies for the Treatment of Cancer
Immunorizon

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!